Subscribe Subscribe   Find us on Twitter Follow POL on Twitter  



Lowe on FDA advisory panels

Derek Lowe, known for his "Pipeline" blog at Corante on pharmaceutical issues, has a piece at Medical Progress Today -- which, like this site, is produced by the Manhattan Institute -- commenting on proposals to ban from Food and Drug Administration advisory panels all scientists who have dealings with companies whose drugs are under consideration. Lowe thinks the proposals likely to do more harm than good.



Rafael Mangual
Project Manager,
Legal Policy

Manhattan Institute


Published by the Manhattan Institute

The Manhattan Insitute's Center for Legal Policy.